We are live on ! Find out more
CA

CHI Advisors Portfolio holdings

AUM $252M
1-Year Est. Return 56.99%
This Fund
S&P 500
This Quarter Est. Return
+13.19%
1 Year Est. Return
+56.99%
3 Year Est. Return
+88.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$500M
AUM Growth
+$145M
Cap. Flow
+$168M
Cap. Flow %
33.56%
Top 10 Hldgs %
91.39%
Holding
26
New
3
Increased
6
Reduced
11
Closed
5
Avg Time Held Equity + Options
3.6 quarters
Top 10 Avg Time Held Equity + Options
2.1 quarters
Top 20 Avg Time Held Equity + Options
3.5 quarters
Avg Time Held Equity only
3.6 quarters
Top 10 Avg Time Held Equity only
2.1 quarters
Top 20 Avg Time Held Equity only
3.5 quarters

Top Buys

Rank Stock Value
1
CGEM icon
Cullinan Oncology
CGEM
+$89.4M
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$59.3M
3
IMA icon
ImageneBio Inc
IMA
+$23.3M
4
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$7.96M
5
ONCR
Oncorus, Inc.
ONCR
+$1.9M

Top Sells

Rank Stock Value
1
AMWL icon
American Well
AMWL
+$6.29M
2
KROS icon
Keros Therapeutics
KROS
+$2.12M
3
OVID icon
Ovid Therapeutics
OVID
+$1.93M
4
DTIL icon
Precision BioSciences
DTIL
+$1.88M
5
INZY icon
Inozyme Pharma
INZY
+$1.5M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
GBT
26
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-20,000
Closed -$8K –
1
2

Similar funds

SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
T
TRUADVICE Sarasota, Florida $255M AUM 14.45% 1-Year Est. Return
W
WealthOne Albany, New York $248M AUM 17.79% 1-Year Est. Return
RBGI
Ribbit Bullfrog GP II Palo Alto, California $258M AUM 33.43% 1-Year Est. Return
TOGEPT
Trustees of General Electric Pension Trust Norwalk, Connecticut $245M AUM 128.88% 1-Year Est. Return
IAM
Innovis Asset Management Chicago, Illinois $260M AUM 28.13% 1-Year Est. Return
RCGI
Ribbit Capital GP II Palo Alto, California $260M AUM 2.87% 1-Year Est. Return
AEPLI
AH Equity Partners LSV III Menlo Park, California $262M AUM 59.24% 1-Year Est. Return

CHI Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, CHI Advisors held 26 positions worth $500M, up 41% from $355M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

CHI Advisors deployed $168M of net new capital in Q1 2021, opening 3 new positions and adding to 6 existing holdings. Its largest new stake was Cullinan Oncology: 2,202,407 shares worth $91.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

On the sell side, the largest reduction was Keros Therapeutics, an estimated $2.12M trimmed.

  • CHI Advisors's largest Q1 2021 buy was Cullinan Oncology: 2,202,407 shares worth $91.8M.
  • CHI Advisors added most to Orchard Therapeutics plc American Depositary Shares in Q1 2021, an estimated $7.96M increase.
  • CHI Advisors's biggest Q1 2021 reduction was Keros Therapeutics, cutting an estimated $2.12M.
  • CHI Advisors fully exited American Well in Q1 2021, selling an estimated $6.29M.
  • CHI Advisors's ten largest holdings make up 91% of its $500M portfolio in Q1 2021.
  • CHI Advisors opened 3 new positions and closed 5 in Q1 2021.
  • CHI Advisors's portfolio value rose 41% quarter-over-quarter to $500M.

Based on CHI Advisors's 13F filing for Q1 2021, filed 14 May 2021.